World News: 21:05 GMT Thursday 29th August 2019. [Menlo Therapeutics Inc. via Globe Newswire via SPi World News]
REDWOOD CITY Calif Aug 29 2019 GLOBE NEWSWIRE -- Menlo Therapeutics Inc LINK MNLO a late-stage biopharmaceutical company focused on the development of serlopitant for the LINK of pruritus itch today announced that LINK Ba ll, chi...
More news and information about Menlo Therapeutics Inc.
Globe Newswire: 21:05 GMT Thursday 29th August 2019
Published: 2019-08-29T21:05:00.
Search for other references to "menlo" on SPi News
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us